Tag: Biogen

Biogen has secured two significant advancements that could reinvigorate the biotechnology company's growth trajectory. Recent developments include a streamlined treatment ...

The investment community finds itself deeply divided over Biogen's prospects, creating a compelling narrative of contrasting viewpoints. As market experts ...

Biogen finds itself in a curious position, delivering impressive third-quarter 2025 results that simultaneously impressed market analysts and disappointed investors. ...

After an extended period of decline, the biotechnology giant Biogen is demonstrating renewed vigor. A convergence of regulatory victories and ...

Biogen has achieved significant regulatory and clinical milestones for its Alzheimer's treatment Leqembi, positioning the biotechnology firm for potential growth ...

Biogen, the biotechnology giant, finds itself navigating contrasting fortunes as its key therapeutic programs advance on divergent paths. While the ...

Biogen Inc. finds itself at a crucial inflection point. The pharmaceutical giant is navigating a deliberate shift away from its ...